Galmed Pharmaceuticals Ltd. (GLMD)
Q2 2019 Earnings Conference Call
August 5, 2019 8:30 A.M. ET
Company Participants
Allen Baharaff - President and Chief Executive Officer
Yohai Stenzler - Chief Financial Officer
Tali Gorfine - Chief Medical Officer
Liat Hayardeny - Chief Scientific Officer
Conference Call Participants
Yasmeen Rahimi - Roth Capital Partners
Adam Walsh - Stifel
Steve Seedhouse - Raymond James
Ed Arce - H.C. Wainwright
Mayank Mamtani - B. Riley FBR
Presentation
Operator
Good day, and welcome to the Galmed Conference Call to discuss Financial Results for Second Quarter of 2019. Today's conference is